ATE211143T1 - Clavulansäure salz - Google Patents

Clavulansäure salz

Info

Publication number
ATE211143T1
ATE211143T1 AT96301136T AT96301136T ATE211143T1 AT E211143 T1 ATE211143 T1 AT E211143T1 AT 96301136 T AT96301136 T AT 96301136T AT 96301136 T AT96301136 T AT 96301136T AT E211143 T1 ATE211143 T1 AT E211143T1
Authority
AT
Austria
Prior art keywords
acid salt
clavulanic acid
clavulanic
salt
acid
Prior art date
Application number
AT96301136T
Other languages
English (en)
Inventor
George Leo Callewaert
Original Assignee
Spurcourt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE211143(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9503839.4A external-priority patent/GB9503839D0/en
Application filed by Spurcourt Ltd filed Critical Spurcourt Ltd
Application granted granted Critical
Publication of ATE211143T1 publication Critical patent/ATE211143T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/10Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
AT96301136T 1995-02-25 1996-02-21 Clavulansäure salz ATE211143T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9503839.4A GB9503839D0 (en) 1995-02-25 1995-02-25 Claulanic acid salt
GBGB9520915.1A GB9520915D0 (en) 1995-02-25 1995-10-12 Clavulanic acid salt

Publications (1)

Publication Number Publication Date
ATE211143T1 true ATE211143T1 (de) 2002-01-15

Family

ID=26306586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96301136T ATE211143T1 (de) 1995-02-25 1996-02-21 Clavulansäure salz

Country Status (27)

Country Link
US (1) US5726170A (de)
EP (1) EP0729961B1 (de)
JP (1) JPH11501023A (de)
CN (1) CN1175952A (de)
AP (2) AP9701116A0 (de)
AT (1) ATE211143T1 (de)
AU (1) AU691727B2 (de)
BG (1) BG62490B1 (de)
BR (1) BR9607258A (de)
CA (1) CA2213563A1 (de)
CZ (1) CZ266697A3 (de)
DE (1) DE69618045D1 (de)
EE (1) EE9700186A (de)
FI (1) FI973287A (de)
HK (1) HK1006571A1 (de)
IL (1) IL117217A0 (de)
IS (1) IS4541A (de)
MD (1) MD1744F2 (de)
NO (1) NO973744L (de)
NZ (1) NZ301765A (de)
OA (1) OA10444A (de)
PL (1) PL321871A1 (de)
SE (1) SE9703056L (de)
SK (1) SK111197A3 (de)
TR (1) TR199700828T1 (de)
WO (1) WO1996026944A1 (de)
ZA (1) ZA961457B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
DZ2456A1 (fr) * 1997-04-04 2003-01-18 Smithkline Beecham Plc Procédé de préparation de sels de l'acide clavulanique.
US8034120B2 (en) * 2002-12-20 2011-10-11 Ossur Hf Suspension liner system with seal
CN103304583B (zh) * 2013-07-09 2016-01-20 山东新时代药业有限公司 一种从克拉维酸胺盐结晶母液中回收克拉维酸的方法
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN113979856B (zh) * 2021-11-09 2024-04-19 国药集团威奇达药业有限公司 从克拉维酸钾釜残液中回收叔丁胺和异辛酸盐的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157873A (en) * 1920-01-16 1921-08-17 Schneider & Cie Improvements in gas turbines
GB704438A (en) * 1951-04-06 1954-02-24 Chimiotherapie Lab Franc Penicillin preparations for injection
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
BE862211A (fr) * 1977-12-22 1978-06-22 Beecham Group Ltd Agents antibacteriens
DE3063683D1 (en) * 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
MX7417E (es) * 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
EP0719778A1 (de) * 1993-03-26 1996-07-03 Gist-Brocades N.V. Clavulansäure Diaminsalze

Also Published As

Publication number Publication date
NO973744D0 (no) 1997-08-14
DE69618045D1 (de) 2002-01-31
AP9701067A0 (en) 1997-10-31
MD970269A (en) 1999-05-31
SE9703056D0 (sv) 1997-08-25
AP9701116A0 (en) 1997-10-31
OA10444A (en) 2002-03-26
PL321871A1 (en) 1997-12-22
AP749A (en) 1999-07-05
IS4541A (is) 1997-08-08
TR199700828T1 (xx) 1998-04-21
AU4726196A (en) 1996-09-18
ZA961457B (en) 1996-09-26
BR9607258A (pt) 1997-12-30
FI973287A0 (fi) 1997-08-08
IL117217A0 (en) 1996-06-18
BG101884A (en) 1998-10-30
US5726170A (en) 1998-03-10
EP0729961A1 (de) 1996-09-04
CA2213563A1 (en) 1996-09-06
FI973287A (fi) 1997-08-22
NO973744L (no) 1997-08-14
EP0729961B1 (de) 2001-12-19
HK1006571A1 (en) 1999-03-05
SE9703056L (sv) 1997-08-25
CZ266697A3 (en) 1997-11-12
MX9706461A (es) 1998-06-28
BG62490B1 (bg) 1999-12-30
NZ301765A (en) 1999-10-28
WO1996026944A1 (en) 1996-09-06
MD1744F2 (ro) 2001-09-30
CN1175952A (zh) 1998-03-11
EE9700186A (et) 1998-02-16
AU691727B2 (en) 1998-05-21
JPH11501023A (ja) 1999-01-26
SK111197A3 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
TR199802106A3 (tr) Sübstitüe edilmis izokinolin-3-karbon asidi amidleri.
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
PT807102E (pt) Amidas do acido alcoxiimino-acetico
DE69606053T2 (de) Modifizierte fluorsulfonsäure
DE69613600T2 (de) Drehmomentbegrenzer
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
ATE211143T1 (de) Clavulansäure salz
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
FI941149A (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
NO306159B1 (no) 5-arylisoksazol-4-substituerte 2-aminokarboksylsyreforbindelser
TR199501675A2 (tr) Klavulanik asid tuzlari.
IL123213A (en) Alpha-substituted aralkanoic acid derivatives
FI961520A (fi) Heribisidiset atsabisfosfonihappoyhdisteet
BR9408162A (pt) Derivados de ácido 2,3,5,6-tetrafluorbenzóico
KR970004666A (ko) 분리형 캠코더
DK0827503T3 (da) Pyrrolidinylmethylindol-salt
GB2298201B (en) Clavulanic acid salts
GB9520915D0 (en) Clavulanic acid salt
TH30422B (th) เดลต้า-อะมิโน-แกมมา-ไฮดรอกซี-โอเมก้า-อะริล-อัลคาโนอิคแอซิดเอไมด์ชนิดใหม่
BR9505557A (pt) Colpo hístero tracionador
DE59606925D1 (de) 1,6-Naphthyridoncarbonsäurederivate
DE29513778U1 (de) Öse
DE29503651U1 (de) Fahrbahnbegrenzung
GB9411194D0 (en) Clavulanic acid salt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties